Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-016403

Chief Business Officer sold 5,000 shares at $16.01 ($80,050)

From the SEC's structured data for this filing

Trades in this filing

Martin Michael Robert · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-09 Sale : show line 1 in the form −5,000 $16.01 $80,050 206,861 D
Open-market sales · 5,000 sh · avg $16.01 · $80,050
Loading xslF345X03/wf-form4_162862613567685.xml…